Xing-Lai Feng Selected Research

Neutropenia

11/2017	Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.
11/2016	Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing-Lai Feng Research Topics

Disease

5	Nasopharyngeal Carcinoma 01/2019 - 01/2016
2	Neutropenia 11/2017 - 11/2016
1	Anemia 11/2017
1	Thrombocytopenia (Thrombopenia) 11/2017
1	Stomatitis 11/2016
1	Neoplasm Metastasis (Metastasis) 07/2016

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 11/2016
3	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2016
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 11/2016
1	AlbuminsIBA 01/2016
1	C-Reactive ProteinIBA 01/2016

Therapy/Procedure

3	Chemoradiotherapy 01/2019 - 11/2016
2	Induction Chemotherapy 01/2019 - 11/2016
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2016 - 01/2016
1	Neoadjuvant Therapy 11/2017